Emerald to Participate at the 2017 MoneyShow Orlando Investor Conference

Date : 02/09/2017 @ 9:00AM
Source : PR Newswire (Canada)
Stock : Emerald Health Therapeutics (EMH)
Quote : 1.26  0.01 (0.80%) @ 3:59PM

Emerald to Participate at the 2017 MoneyShow Orlando Investor Conference

Emerald Health Therapeutics (TSXV:EMH)
Historical Stock Chart

1 Year : From Sep 2016 to Sep 2017

Click Here for more Emerald Health Therapeutics Charts.

VICTORIA, Feb. 9, 2017 /CNW/ - Emerald Health Therapeutics Inc. (TSXV:EMH) "Emerald" or the "Company" is pleased to announce that it will be presenting at The MoneyShow Orlando, February 8-11, 2017, at Omni Orlando Resort at ChampionsGate. The four-day event includes presentations and panel discussions from over 100 exhibitors across a variety of industries. The cannabis industry will have particularly strong representation, including a special two-day event at which Emerald will be presenting twice:

  • Canada is Leading the Global Cannabis Revolution – February 9, 2017 at 3:30pm: A panel discussion focused as to why Canada, on the cusp of legalization of recreational cannabis, is one of the most exciting markets in the burgeoning cannabis industry globally.
  • A True Medical Approach – February 10, 2017 at 1:15pm: Since inception Emerald has focused on developing cannabis based medicines, backed by clinical efficacy, with standard dosing and conventional delivery mechanisms. This presentation will cover how Emerald plans to achieve this goal.

Visit Emerald at Booth #106 in the exhibit hall throughout the conference.

For more information about the 2017 MoneyShow Orlando visit the conference website, www.orlandomoneyshow.com

Join us on our journey of enhancing health through cannabis science.

For more information, explore our website and investor presentation at www.emeraldhealth.ca.

ON BEHALF OF THE BOARD

Jim Heppell

Lead Director

Emerald Health Therapeutics Inc.

Emerald Health Therapeutics, Inc. operates primarily through Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary of the Company and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). Botanicals is authorized to cultivate and sell both dried medical cannabis flower and medical cannabis oils in Canada. Botanicals currently operates an indoor cultivation facility in Victoria, British Columbia, and plans to construct a much larger purpose built hybrid greenhouse facility on 32 acres in metro Vancouver. Botanicals prides itself on being one of Canada's most medically focused licensed producers and on having one of the industry's most qualified management teams with respect to pharmaceutical drug discovery, development and distribution. Botanicals intends to capture unique niches in both the medical and future adult use cannabis markets through its proprietary strains, defensible intellectual property, and superb client experience.

SOURCE Emerald Health Therapeutics, Inc.

Copyright 2017 Canada NewsWire

Latest TSXV:EMH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.